This study aimed to generate Phd2+/− MØs from mouse embryonic stem cells (ESCs) and to assess their functional properties in vitro as well as their therapeutic efficacy in a murine model of limb ischemia. This evidence concerns the gene EGLN1 and limb ischemia.